Tapewire

Nasdaq · USD

RPRX

Royalty Pharma plc

Export transactions ↓
Tapewire entity
3100
SEC CIK
0001802768
Parsed reports
338

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 2025014
Jan 202609
Feb 202608
Mar 202606
Apr 202604
May 202604
Jun 202607
Jul 202601
Aug 202603
Sep 202603
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2021 Filed Jun 30, 2021 21:11 UTC GrantClass A Ordinary Shares 871 $43.04 $37,489.23
Disclosure

SEC source: 0000950103-21-009780 · dp153692_4-ford.xml · nonDerivative · entry 1

FORD WILLIAM E · CIK 0001193345 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,597

F1 · price: Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Read SEC document
June 30, 2021 Filed Apr 15, 2022 22:55 UTC
Legorreta Pablo G.Director · CEO, Chairman of the Board · 10% owner
OtherICAI Interests · Derivative 73,332 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000950103-22-006475 · dp171092_4-legoretta.xml · derivative · entry 21

Legorreta Pablo G. · CIK 0001507678 · Director · CEO, Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,332

Underlying: Limited Partnership interests in RPI US Partners 2019, LP · 73,332 shares

Expires not disclosed

F10 · kind: Reflects the automatic transfer of ICAI Interests to the Reporting Person for no consideration upon the forfeiture of such ICAI Interests due to the retirement of an employee of RP Management, LLC.

F10 · price: Reflects the automatic transfer of ICAI Interests to the Reporting Person for no consideration upon the forfeiture of such ICAI Interests due to the retirement of an employee of RP Management, LLC.

F6 · derivative.exercise_date: These ICAI Interests represent a grant of up to an equivalent number of RPI US LP Interests and expire on December 15, 2023. The full number of RPI US LP Interests is issuable in respect of these ICAI Interests if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The number of RPI US LP Interests issuable in respect of these ICAI Interests scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.

F6 · derivative.expiration_date: These ICAI Interests represent a grant of up to an equivalent number of RPI US LP Interests and expire on December 15, 2023. The full number of RPI US LP Interests is issuable in respect of these ICAI Interests if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The number of RPI US LP Interests issuable in respect of these ICAI Interests scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.

F7 · derivative.underlying: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.

Read SEC document
June 29, 2021 Filed Jun 30, 2021 00:31 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 479,800 $41.26 $19,794,436.88
Disclosure

SEC source: 0000950103-21-009692 · dp153575_4-riggs.xml · nonDerivative · entry 5

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 3,451,258

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.87 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 29, 2021 Filed Jun 30, 2021 00:31 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 1,200 $42.01 $50,408.76
Disclosure

SEC source: 0000950103-21-009692 · dp153575_4-riggs.xml · nonDerivative · entry 4

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 3,931,058

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 28, 2021 Filed Jun 30, 2021 00:31 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 167,448 $42.11 $7,051,268.77
Disclosure

SEC source: 0000950103-21-009692 · dp153575_4-riggs.xml · nonDerivative · entry 3

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 3,932,258

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.90 to $42.79 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:31 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 487,364 $42.69 $20,807,518.62
Disclosure

SEC source: 0000950103-21-009692 · dp153575_4-riggs.xml · nonDerivative · entry 2

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 4,099,706

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.33 to $43.04 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:31 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 179,100 $42.81 $7,666,500.87
Disclosure

SEC source: 0000950103-21-009692 · dp153575_4-riggs.xml · nonDerivative · entry 1

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures Select

Disclosed balance after: 933,910

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.44 to $43.29 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:43 UTC
LOVE TED WDirector
GrantClass A Ordinary Shares 5,726 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-009695 · dp153556_4-love.xml · nonDerivative · entry 1

LOVE TED W · CIK 0001188919 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,866

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

F2 · balance_after: Reflects an adjustment to the number of Class A Ordinary Shares beneficially owned by the reporting person based on the actual number of shares delivered to the reporting person upon the settlement of an award of restricted stock units granted to the reporting person as reported on August 13, 2020.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:34 UTC GrantClass A Ordinary Shares 5,726 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-009693 · dp153554_4-desouza.xml · nonDerivative · entry 1

DESOUZA ERROL B · CIK 0001213895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,370

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:30 UTC GrantClass A Ordinary Shares 5,726 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-009691 · dp153551_4-bassler.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,909

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:29 UTC GrantClass A Ordinary Shares 5,726 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-009690 · dp153557_4-ford.xml · nonDerivative · entry 1

FORD WILLIAM E · CIK 0001193345 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,726

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:28 UTC GrantClass A Ordinary Shares 5,726 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-009689 · dp153553_4-fernandez.xml · nonDerivative · entry 1

Fernandez Henry A · CIK 0001416750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,115

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

F2 · balance_after: Reflects an adjustment to the number of Class A Ordinary Shares beneficially owned by the reporting person based on the actual number of shares delivered to the reporting person upon the settlement of an award of restricted stock units granted to the reporting person as reported on August 13, 2020.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:26 UTC GrantClass A Ordinary Shares 5,726 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-009688 · dp153555_4-norden.xml · nonDerivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,370

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:22 UTC GrantClass A Ordinary Shares 5,726 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-009687 · dp153558_4-engelbert.xml · nonDerivative · entry 1

Engelbert Catherine M. · CIK 0001796439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,136

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 18:42 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 10,000 $46.45 $464,491.00
Disclosure

SEC source: 0000950103-21-008761 · dp152652_4-lloyd.xml · nonDerivative · entry 3

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2020 G, LLC

Disclosed balance after: 240,000

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.65 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 18:42 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 40,000 $46.52 $1,860,772.00
Disclosure

SEC source: 0000950103-21-008761 · dp152652_4-lloyd.xml · nonDerivative · entry 2

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 880,000

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.69 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 18:42 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 20,000 $46.46 $929,106.00
Disclosure

SEC source: 0000950103-21-008761 · dp152652_4-lloyd.xml · nonDerivative · entry 1

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 620,860

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.66 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 08, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 10,000 $46.47 $464,747.00
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 12

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2020 G, LLC

Disclosed balance after: 250,000

F12 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.70 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 08, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 40,000 $46.48 $1,859,344.00
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 11

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 920,000

F11 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.69 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 08, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 20,000 $46.48 $929,540.00
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 10

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 640,860

F10 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 00:12 UTC
Reddoch James F.EVP, Research & Investments
SaleClass A Ordinary Shares 50,000 $46.43 $2,321,540.00
Disclosure

SEC source: 0000950103-21-008570 · dp152445_4-reddoch.xml · nonDerivative · entry 4

Reddoch James F. · CIK 0001814872 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 1,270,800

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.30 to $46.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 4,853 $46.54 $225,859.11
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 9

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2020 G, LLC

Disclosed balance after: 260,000

F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.44 to $46.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 15,147 $45.89 $695,109.46
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 8

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2020 G, LLC

Disclosed balance after: 264,853

F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.34 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 36,619 $46.74 $1,711,696.56
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 7

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 960,000

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.07 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 33,381 $46.10 $1,538,767.30
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 6

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 996,619

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.49 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 13,400 $46.77 $626,719.34
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 5

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 660,860

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 19,100 $45.97 $878,076.66
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 4

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 674,260

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.48 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 00:13 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 273,650 $45.26 $12,385,399.00
Disclosure

SEC source: 0000950103-21-008572 · dp152446_4-riggs.xml · nonDerivative · entry 1

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures III LLC

Disclosed balance after: 2,081,540

Read SEC document
June 07, 2021 Filed Jun 9, 2021 00:15 UTC
Urist MarshallEVP & Co-Head of R&I
SaleClass A Ordinary Shares 16,568 $47.02 $779,058.84
Disclosure

SEC source: 0000950103-21-008573 · dp152447_4-urist.xml · nonDerivative · entry 2

Urist Marshall · CIK 0001838139 · EVP & Co-Head of R&I

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 00:12 UTC
Reddoch James F.EVP, Research & Investments
SaleClass A Ordinary Shares 2,210 $47.01 $103,896.30
Disclosure

SEC source: 0000950103-21-008570 · dp152445_4-reddoch.xml · nonDerivative · entry 3

Reddoch James F. · CIK 0001814872 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 1,320,800

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Such transactions were effected pursuant to a 10b5-1 plan adopted by the reporting person on December 30, 2020.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 00:12 UTC
Reddoch James F.EVP, Research & Investments
SaleClass A Ordinary Shares 47,790 $46.57 $2,225,522.95
Disclosure

SEC source: 0000950103-21-008570 · dp152445_4-reddoch.xml · nonDerivative · entry 2

Reddoch James F. · CIK 0001814872 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 1,323,010

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Such transactions were effected pursuant to a 10b5-1 plan adopted by the reporting person on December 30, 2020.

Read SEC document
June 04, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 20,000 $44.81 $896,204.00
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 3

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2020 G, LLC

Disclosed balance after: 280,000

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.72 to $44.89 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 04, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 20,000 $44.85 $897,028.00
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 2

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 1,030,000

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.53 to $45.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 04, 2021 Filed Jun 8, 2021 20:12 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 20,000 $44.69 $893,706.00
Disclosure

SEC source: 0000950103-21-008571 · dp152452_4-lloyd.xml · nonDerivative · entry 1

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 693,360

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.15 to $45.04 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 04, 2021 Filed Jun 9, 2021 00:15 UTC
Urist MarshallEVP & Co-Head of R&I
SaleClass A Ordinary Shares 16,566 $45.13 $747,661.68
Disclosure

SEC source: 0000950103-21-008573 · dp152447_4-urist.xml · nonDerivative · entry 1

Urist Marshall · CIK 0001838139 · EVP & Co-Head of R&I

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,568

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.37 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 04, 2021 Filed Jun 9, 2021 00:12 UTC
Reddoch James F.EVP, Research & Investments
SaleClass A Ordinary Shares 100,000 $44.60 $4,459,730.00
Disclosure

SEC source: 0000950103-21-008570 · dp152445_4-reddoch.xml · nonDerivative · entry 1

Reddoch James F. · CIK 0001814872 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 1,370,800

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.14 to $45.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 18:48 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 50,000 $42.13 $2,106,385.00
Disclosure

SEC source: 0000950103-21-008456 · dp152316_4-lloyd.xml · nonDerivative · entry 2

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 1,050,000

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.56 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 18:48 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 12,500 $42.09 $526,127.50
Disclosure

SEC source: 0000950103-21-008456 · dp152316_4-lloyd.xml · nonDerivative · entry 1

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 713,360

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.26 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 22:52 UTC
Urist MarshallEVP & Co-Head Research & Inv.
SaleClass A Ordinary Shares 14,566 $41.52 $604,850.24
Disclosure

SEC source: 0000950103-21-008458 · dp152317_4-urist.xml · nonDerivative · entry 1

Urist Marshall · CIK 0001838139 · EVP & Co-Head Research & Inv.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,134

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.18 to $41.86 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 22:50 UTC
Reddoch James F.EVP, Research & Investments
SaleClass A Ordinary Shares 50,000 $42.13 $2,106,560.00
Disclosure

SEC source: 0000950103-21-008457 · dp152318_4-reddoch.xml · nonDerivative · entry 1

Reddoch James F. · CIK 0001814872 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 1,470,800

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.63 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 21, 2021 Filed May 25, 2021 00:10 UTC
Urist MarshallEVP & Co-Head Research & Inv.
SaleClass A Ordinary Shares 100 $41.00 $4,100.00
Disclosure

SEC source: 0000950103-21-007749 · dp151622_4-urist.xml · nonDerivative · entry 2

Urist Marshall · CIK 0001838139 · EVP & Co-Head Research & Inv.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,700

Read SEC document
May 20, 2021 Filed May 25, 2021 00:10 UTC
Urist MarshallEVP & Co-Head Research & Inv.
SaleClass A Ordinary Shares 1,900 $41.08 $78,059.03
Disclosure

SEC source: 0000950103-21-007749 · dp151622_4-urist.xml · nonDerivative · entry 1

Urist Marshall · CIK 0001838139 · EVP & Co-Head Research & Inv.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,800

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.20 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 07, 2021 Filed May 11, 2021 21:05 UTC
Lloyd George W.EVP, Investments & GC
ConversionLP interests in RPI US Partners 2019, LP · Derivative 30,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007076 · dp150858_4-lloyd.xml · derivative · entry 8

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2020 G, LLC

Disclosed balance after: 264,027

Underlying: Class A Ordinary Shares · 300,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F3 · derivative.exercise_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F3 · derivative.expiration_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F2 · balance_after: The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.

Read SEC document
May 07, 2021 Filed May 11, 2021 21:05 UTC
Lloyd George W.EVP, Investments & GC
ConversionLP interests in RPI US Partners 2019, LP · Derivative 90,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007076 · dp150858_4-lloyd.xml · derivative · entry 7

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 172,680

Underlying: Class A Ordinary Shares · 900,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F3 · derivative.exercise_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F3 · derivative.expiration_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F2 · balance_after: The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.

Read SEC document
May 07, 2021 Filed May 11, 2021 21:05 UTC
Lloyd George W.EVP, Investments & GC
ConversionLP interests in RPI US Partners 2019, LP · Derivative 67,586 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007076 · dp150858_4-lloyd.xml · derivative · entry 6

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 675,860 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F3 · derivative.exercise_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F3 · derivative.expiration_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

Read SEC document
May 07, 2021 Filed May 11, 2021 21:05 UTC
Lloyd George W.EVP, Investments & GC
ConversionClass A Ordinary Shares 300,000 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007076 · dp150858_4-lloyd.xml · nonDerivative · entry 3

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2020 G, LLC

Disclosed balance after: 300,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F1 · price: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F2 · balance_after: The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.

Read SEC document
May 07, 2021 Filed May 11, 2021 21:05 UTC
Lloyd George W.EVP, Investments & GC
ConversionClass A Ordinary Shares 900,000 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007076 · dp150858_4-lloyd.xml · nonDerivative · entry 2

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 1,100,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F1 · price: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F2 · balance_after: The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.

Read SEC document
May 07, 2021 Filed May 11, 2021 21:05 UTC
Lloyd George W.EVP, Investments & GC
ConversionClass A Ordinary Shares 675,860 $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007076 · dp150858_4-lloyd.xml · nonDerivative · entry 1

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2013 NG, LLC

Disclosed balance after: 725,860

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F1 · price: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F2 · balance_after: The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.

Read SEC document
May 07, 2021 Filed May 12, 2021 01:00 UTC
RIGGS RORY BDirector
ConversionLP interests in RPI US Partners 2019, LP · Derivative 235,519 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007074 · dp150860_4-riggs.xml · derivative · entry 7

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures III LLC

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 2,355,190 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F2 · derivative.exercise_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F2 · derivative.expiration_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

Read SEC document
May 07, 2021 Filed May 12, 2021 01:00 UTC
RIGGS RORY BDirector
ConversionLP interests in RPI US Partners 2019, LP · Derivative 67,976 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950103-21-007074 · dp150860_4-riggs.xml · derivative · entry 6

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 541,751

Underlying: Class A Ordinary Shares · 679,760 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F2 · derivative.exercise_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F2 · derivative.expiration_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.